Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
bictegravir-emtricitabine-tenofovir alafenamide
bictegravir-emtricitabine-tenofovir alafenamide
- Formulary
Last updated: May. 18, 2022
- Black Box Warning: Post Treatment Acute Exacerbation of Hepatitis B
- Formulary, Not Routinely Stocked:
Biktarvy is formulary, not routinely stocked. Home supply should be used if available.
If/When bictegravir is available as an individual agent, Biktarvy will be substituted to individual components.
Reviewed: 28 Aug 2018 (Biktarvy)